Treatment of GI Bleeding Due to Portal Hypertensive Gastropathy

Introduction to Portal Hypertensive Gastropathy Management

Portal hypertensive gastropathy bleeding should be managed primarily with portal hypertension-lowering measures, including vasoactive therapy in the acute setting and beta-blockers for chronic management, as recommended by the European Association for the Study of the Liver 1, 2, 3

Initial stabilization and medical management of portal hypertensive gastropathy bleeding involves following standard portal hypertensive bleeding protocols with vasoactive drugs, such as terlipressin or octreotide, to reduce splanchnic blood flow, as suggested by the American Association for the Study of Liver Diseases 1, 3
A restrictive red blood cell transfusion strategy should be used to avoid increasing portal pressure, according to the European Association for the Study of the Liver 2
A short course of prophylactic antibiotics is recommended, as stated by the World Society of Emergency Surgery 4

Non-selective beta-blockers, such as propranolol, are the first-line pharmacological therapy for chronic management, aiming to reduce hepatic venous pressure gradient by 10-12%, as recommended by the American College of Gastroenterology 1, 3, 5, 6
For patients who fail beta-blocker therapy or cannot tolerate it, transjugular intrahepatic portosystemic shunt (TIPS) is recommended to reduce portal pressure and lessen the severity of portal hypertensive gastropathy, as suggested by the European Association for the Study of the Liver 1, 3, 7

Iron supplementation is recommended for chronic blood loss and anemia, as stated by the Clinical and Molecular Hepatology society 6
Addressing underlying liver disease and portal hypertension causes is crucial, according to the Praxis Medical Insights society 5

Hemostatic abnormalities should be corrected on a case-by-case basis in case of failure to control hemorrhage with portal hypertension-lowering drugs, as recommended by the European Association for the Study of the Liver 1, 3
Regular endoscopic surveillance is necessary to assess portal hypertensive gastropathy severity, as suggested by the Clinical and Molecular Hepatology society 6

Large volume transfusions should be avoided as they may paradoxically increase portal pressure and worsen bleeding, according to the European Association for the Study of the Liver and the Praxis Medical Insights society 2, 5
Portal hypertensive gastropathy bleeding accounts for 2-12% of all GI bleeding episodes in cirrhotic patients, as reported by the European Association for the Study of the Liver 1, 3